Collagen Cross-Linking (also called Corneal Cross-Linking or CXL) is a minimally invasive treatment used to slow or stop the progression of keratoconus — a condition that causes the cornea to thin and bulge outward.
The procedure strengthens the cornea by applying specially formulated riboflavin (vitamin B2) eye drops, followed by controlled ultraviolet (UV) light. This combination creates new collagen bonds, reinforcing the corneal structure.
Keratoconus is a progressive eye condition that causes the cornea to weaken and take on a cone-like shape. It can lead to distorted vision, increased light sensitivity, and a rapid change in eyeglass prescriptions. Early diagnosis and treatment are key to preserving long-term vision.
Collagen Cross-Linking is most effective when performed in the early or moderate stages of keratoconus. You may be a candidate if:
Cross-Linking is a painless outpatient procedure performed in under an hour.
Most patients experience mild irritation and light sensitivity for a few days. Our team provides detailed post-op care instructions to ensure a smooth healing process.
The goal of cross-linking is to preserve vision by halting further corneal weakening. While it doesn’t reverse keratoconus, it may prevent the need for a corneal transplant later on.
If you’ve been diagnosed with keratoconus or suspect you may have it, schedule a consultation with our experienced team today. Early intervention is key.
Let us know how we can help — our team will reach out shortly to confirm your consultation and answer any questions.
